Litcius/Paper detail

Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India

Avneet Garg, Ullas Batra, Priyanshu Choudhary, Deepali Jain, Sachin Khurana, Prabhat Singh Malik, Valliappan Muthu, Kuruswamy Thurai Prasad, Navneet Singh, Tejas Menon Suri, Anant Mohan

2020Current Problems in Cancer24 citationsDOI

Topics & Concepts

MedicineGefitinibErlotinibInternal medicineLung cancerOncologyEpidermal growth factor receptorUnivariate analysisBrain metastasisTargeted therapyCohortRetrospective cohort studyCancerTyrosine-kinase inhibitorErlotinib HydrochlorideMetastasisMultivariate analysisLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India | Litcius